Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001956559-22-000001
Filing Date
2022-12-01
Accepted
2022-11-30 20:55:35
Documents
1
Effectiveness Date
2022-12-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10247
  Complete submission text file 0001956559-22-000001.txt   11342
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SUITE 525 SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SUITE 525 SAN FRANCISCO CA 94158 415-310-4524
Rezo Therapeutics, Inc. (Filer) CIK: 0001956559 (see all company filings)

EIN.: 874039235 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-466228 | Film No.: 221437046